Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
8.55M
-
Shares change
-
+4.35M
-
Total reported value, excl. options
-
$159M
-
Value change
-
+$86.1M
-
Put/Call ratio
-
0.22
-
Number of buys
-
50
-
Number of sells
-
-18
-
Price
-
$18.57
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q3 2020
78 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q3 2020.
IMMUNIC, INC. - Common Stock (IMUX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.55M shares
of 120M outstanding shares and own 7.11% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.79M shares), FMR LLC (996K shares), RTW INVESTMENTS, LP (912K shares), Artal Group S.A. (800K shares), VANGUARD GROUP INC (650K shares), BlackRock Inc. (501K shares), Parkman Healthcare Partners LLC (400K shares), MILLENNIUM MANAGEMENT LLC (333K shares), Ghost Tree Capital, LLC (265K shares), and Invesco Ltd. (251K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.